Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Comment on: Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS)
Radiother Oncol. 2024 Mar 23:110254. doi: 10.1016/j.radonc.2024.110254. Online ahead of print.NO ABSTRACTPMID:38527627 | DOI:10.1016/j.radonc.2024.110254 (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 25, 2024 Category: Radiology Authors: Hua-Qing Niu Bo-Yv Zheng Ming-Xiang Zou Tao-Lan Zhang Bo-Wen Zheng Source Type: research

Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer
CONCLUSION: SBRT is a safe and valid option in oligometastatic breast cancer patients, with very high rates of local control. An optimal selection of patients is likely needed to improve survival outcomes and reduce the rate of distant progression.PMID:38522597 | DOI:10.1016/j.radonc.2024.110240 (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 24, 2024 Category: Radiology Authors: D Franceschini C Franzese T Comito M B Ilieva R Spoto A M Marzo L Dominici M Massaro L Bellu M Badalamenti P Mancosu M Scorsetti Source Type: research

In reply to Niu et al: Meta-analysis of 5-day preoperative radiotherapy for soft tissue sarcoma (5D-PREORTS)
Radiother Oncol. 2024 Mar 22:110255. doi: 10.1016/j.radonc.2024.110255. Online ahead of print.NO ABSTRACTPMID:38522598 | DOI:10.1016/j.radonc.2024.110255 (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 24, 2024 Category: Radiology Authors: Fabio L Cury Gustavo A Viani Andre G Gouveia Fabio Y Moraes Source Type: research

Risk of clinically significant cardiovascular disease associated with postoperative radiotherapy in non-small cell lung cancer patients receiving surgical resection followed by adjuvant chemotherapy: A Korean nationwide cohort study
CONCLUSIONS: These results suggest that PORT had no significant impact on various CVD occurrences in NSCLC patients without underlying heart disease.PMID:38522599 | DOI:10.1016/j.radonc.2024.110241 (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 24, 2024 Category: Radiology Authors: Jeanny Kwon Byoung Hyuck Kim Source Type: research

Neutrophil-to-lymphocyte ratio for the prediction of soft tissue sarcomas response to pre-operative radiation therapy
CONCLUSION: This study is the first to evaluate NLR as a prognostic biomarker in STS patients treated with pre-operative radiotherapy. A higher NLR after pre-operative radiotherapy was associated with increased disease progression.PMID:38521165 | DOI:10.1016/j.radonc.2024.110239 (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 23, 2024 Category: Radiology Authors: Constanza Martinez Rie Asso Neelabh Rastogi Carolyn Freeman Fabio Cury Source Type: research

Chronic fatigue in long-term survivors of head and neck cancer treated with radiotherapy
CONCLUSIONS: CF in HNC survivors is particularly important for female patients, while specific factors associated with RT appear not to play a role. The high CF prevalence in long-term HNC survivors associated with impaired HRQoL is important information beneficial for clinicians and patients to improve patient follow-up.PMID:38518958 | DOI:10.1016/j.radonc.2024.110231 (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 22, 2024 Category: Radiology Authors: Thuy-Tien Maria Huynh Ragnhild S ørum Falk Taran Paulsen Hellebust Einar Dale Guro Lindviksmoen Astrup Marianne Jensen Hjermstad Eirik Malinen Kristin Bjordal Cecilie Essholt Kiserud Bente Brokstad Herlofson Ragnhild Nome Cecilie Delphin Amdal Source Type: research

In Memoriam: C. Norman Coleman, M.D., (1945-2024)
Radiother Oncol. 2024 Mar 19;194:110228. doi: 10.1016/j.radonc.2024.110228. Online ahead of print.NO ABSTRACTPMID:38513554 | DOI:10.1016/j.radonc.2024.110228 (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 21, 2024 Category: Radiology Authors: Jeffrey C Buchsbaum Frank S Govern Pataje Prasanna Source Type: research

Organs-at-risk dose and normal tissue complication probability with dynamic trajectory radiotherapy (DTRT) for head and neck cancer
Radiother Oncol. 2024 Mar 20;195:110237. doi: 10.1016/j.radonc.2024.110237. Online ahead of print.ABSTRACTWe compared dynamic trajectory radiotherapy (DTRT) to state-of-the-art volumetric modulated arc therapy (VMAT) for 46 head and neck cancer cases. DTRT had lower dose to salivary glands and swallowing structure, resulting in lower predicted xerostomia and dysphagia compared to VMAT. DTRT is deliverable on C-arm linacs with high dosimetric accuracy.PMID:38513960 | DOI:10.1016/j.radonc.2024.110237 (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 21, 2024 Category: Radiology Authors: Jenny Bertholet Paul-Henry Mackeprang Hannes A Loebner Silvan Mueller Gian Guyer Daniel Frei Werner Volken Olgun Elicin Daniel M Aebersold Michael K Fix Peter Manser Source Type: research

Organs-at-risk dose and normal tissue complication probability with dynamic trajectory radiotherapy (DTRT) for head and neck cancer
Radiother Oncol. 2024 Mar 19:110237. doi: 10.1016/j.radonc.2024.110237. Online ahead of print.ABSTRACTWe compared dynamic trajectory radiotherapy (DTRT) to state-of-the-art volumetric modulated arc therapy (VMAT) for 46 head and neck cancer cases. DTRT had lower dose to salivary glands and swallowing structure, resulting in lower predicted xerostomia and dysphagia compared to VMAT. DTRT is deliverable on C-arm linacs with high dosimetric accuracy.PMID:38513960 | DOI:10.1016/j.radonc.2024.110237 (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 21, 2024 Category: Radiology Authors: Jenny Bertholet Paul-Henry Mackeprang Hannes A Loebner Silvan Mueller Gian Guyer Daniel Frei Werner Volken Olgun Elicin Daniel M Aebersold Michael K Fix Peter Manser Source Type: research

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E < sup > 2 < /sup > -RADIatE OligoCare study
CONCLUSION: This real-world analysis suggests that SBRT doses are adjusted to the primary cancers and oligometastasis location. Future analysis will address safety and efficacy of this site- and disease-adapted SBRT fractionation approach (NCT03818503).PMID:38508239 | DOI:10.1016/j.radonc.2024.110235 (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 20, 2024 Category: Radiology Authors: Sebastian M Christ Filippo Alongi Umberto Ricardi Marta Scorsetti Lorenzo Livi Panagiotis Balermpas Yolande Lievens P ètra Braam Barbara Alicja Jereczek-Fossa Karin Stellamans Ivica Ratosa Joachim Widder Heike Peulen Piet Dirix Samuel Bral Sara Ramella H Source Type: research

Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer
CONCLUSIONS: Two-year lymphopenia after PNI for PCa is largely modulated by baseline ALC, with an independent role of acute G3+ lymphopenia. BMLS-V24 was the best dosimetry predictor: constraints for BMTOT (V10Gy < 1520 cc, V20Gy < 1250 cc, V30Gy < 850 cc), and BMLS (V24y < 307 cc) were suggested to potentially reduce the risk.PMID:38503355 | DOI:10.1016/j.radonc.2024.110230 (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 19, 2024 Category: Radiology Authors: Maddalena Pavarini Lisa Alborghetti Stefania Aimonetto Angelo Maggio Valeria Landoni Paolo Ferrari Antonella Bianculli Edoardo Petrucci Alessandro Cicchetti Bruno Farina Maria Giulia Ubeira-Gabellini Paolo Salmoiraghi Eugenia Moretti Barbara Avuzzi Tommas Source Type: research

Proton beam radiotherapy head and neck cancer study design and endpoints
Radiother Oncol. 2024 Mar 16:110234. doi: 10.1016/j.radonc.2024.110234. Online ahead of print.NO ABSTRACTPMID:38499271 | DOI:10.1016/j.radonc.2024.110234 (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 18, 2024 Category: Radiology Authors: Cheng S Boon Shanmugasundaram Ramkumar Ian S Boon Source Type: research